Abstract
Ataxia telangiectasia mutated (ATM) mediates DNA damage response by controling irradiation-induced foci formation, cell cycle checkpoint, and apoptosis. However, how upstream signaling regulates ATM is not completely understood. Here, we show that upon irradiation stimulation, ATM associates with and is phosphorylated by epidermal growth factor receptor (EGFR) at Tyr370 (Y370) at the site of DNA double-strand breaks. Depletion of endogenous EGFR impairs ATM-mediated foci formation, homologous recombination, and DNA repair. Moreover, pretreatment with an EGFR kinase inhibitor, gefitinib, blocks EGFR and ATM association, hinders CHK2 activation and subsequent foci formation, and increases radiosensitivity. Thus, we reveal a critical mechanism by which EGFR directly regulates ATM activation in DNA damage response, and our results suggest that the status of ATM Y370 phosphorylation has the potential to serve as a biomarker to stratify patients for either radiotherapy alone or in combination with EGFR inhibition.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Harper JW, Elledge SJ . The DNA damage response: ten years after. Mol Cell 2007; 28:739–745.
Lee JH, Paull TT . Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 2007; 26:7741–7748.
Lavin MF . Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9:759–769.
Kozlov SV, Graham ME, Peng C, et al. Involvement of novel autophosphorylation sites in ATM activation. EMBO J 2006; 25:3504–3514.
Bakkenist CJ, Kastan MB . DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499–506.
Lavin MF, Kozlov S . ATM activation and DNA damage response. Cell Cycle 2007; 6:931–942.
Lavin MF . ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 2007; 26:7749–7758.
Jiang H, Reinhardt HC, Bartkova J, et al. The combined status of ATM and p53 link tumor development with therapeutic response. Genes Dev 2009; 23:1895–1909.
Chun HH, Gatti RA . Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 2004; 3:1187–1196.
Tribius S, Pidel A, Casper D . ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys 2001; 50:511–523.
Yarden Y, Sliwkowski MX . Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2:127–137.
Lin SY, Makino K, Xia W, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001; 3:802–808.
Cao H, Lei ZM, Bian L, et al. Functional nuclear epidermal growth factor receptors in human choriocarcinoma JEG-3 cells and normal human placenta. Endocrinology 1995; 136:3163–3172.
Dittmann K, Mayer C, Fehrenbacher B, et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 2005; 280:31182–31189.
Lo HW, Hung MC . Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer 2006; 94:184–188.
Wang YN, Yamaguchi H, Hsu JM, et al. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 2010; 29:3997–4006.
Lo HW, Hsu SC, Ali-Seyed M, et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005; 7:575–589.
Hung LY, Tseng JT, Lee YC, et al. Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 2008; 36:4337–4351.
Bandyopadhyay D, Mandal M, Adam L, et al. Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J Biol Chem 1998; 273:1568–1573.
Yu YL, Chou RH, Wu CH, et al. Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. J Biol Chem 2012; 287:31015–31026.
Wang SC, Nakajima Y, Yu YL, et al. Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 2006; 8:1359–1368.
Yu YL, Chou RH, Liang JH, et al. Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides. PLoS One 2013; 8:e61362.
Zhao H, Lo YH, Ma L, et al. Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth. Mol Cancer Ther 2011; 10:29–36.
Pellegrini M, Celeste A, Difilippantonio S, et al. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature 2006; 443:222–225.
Daniel JA, Pellegrini M, Lee JH, et al. Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo. J Cell Biol 2008; 183:777–783.
Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160–1166.
Kozlov SV, Graham ME, Jakob B, et al. Autophosphorylation and ATM activation: additional sites add to the complexity. J Biol Chem 2011; 286:9107–9119.
Bennetzen MV, Larsen DH, Bunkenborg J, et al. Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 2010; 9:1314–1323.
Khanna KK, Keating KE, Kozlov S, et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 1998; 20:398–400.
Wang SC, Hung MC . Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors. Clin Cancer Res 2009; 15:6484–6489.
Dittmann K, Mayer C, Kehlbach R, et al. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer 2008; 7:69.
Peng G, Yim EK, Dai H, et al. BRIT1/MCPH1 links chromatin remodelling to DNA damage response. Nat Cell Biol 2009; 11:865–872.
Lan L, Nakajima S, Komatsu K, et al. Accumulation of Werner protein at DNA double-strand breaks in human cells. J Cell Sci 2005; 118:4153–4162.
Lan L, Nakajima S, Oohata Y, et al. In situ analysis of repair processes for oxidative DNA damage in mammalian cells. Proc Natl Acad Sci USA 2004; 101:13738–13743.
Uziel T, Lerenthal Y, Moyal L, et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 2003; 22:5612–5621.
Lee JH, Paull TT . Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004; 304:93–96.
Lee JH, Paull TT . ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 2005; 308:551–554.
Kastan MB, Lim DS . The many substrates and functions of ATM. Nat Rev Mol Cell Biol 2000; 1:179–186.
Cortez D, Wang Y, Qin J, et al. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 1999; 286:1162–1166.
Lukas J, Lukas C, Bartek J . More than just a focus: the chromatin response to DNA damage and its role in genome integrity maintenance. Nat Cell Biol 2011; 13:1161–1169.
MacPhail SH, Banath JP, Yu TY, et al. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 2003; 79:351–358.
Taneja N, Davis M, Choy JS, et al. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 2004; 279:2273–2280.
Iijima K, Ohara M, Seki R, et al. Dancing on damaged chromatin: functions of ATM and the RAD50/MRE11/NBS1 complex in cellular responses to DNA damage. J Radiat Res 2008; 49:451–464.
Morrison C, Sonoda E, Takao N, et al. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J 2000; 19:463–471.
Zhou BB, Chaturvedi P, Spring K, et al. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem 2000; 275:10342–10348.
Matsuoka S, Rotman G, Ogawa A, et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 2000; 97:10389–10394.
Ahn JY, Schwarz JK, Piwnica-Worms H, et al. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res 2000; 60:5934–5936.
Ward IM, Wu X, Chen J . Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks. J Biol Chem 2001; 276:47755–47758.
White DE, Negorev D, Peng H, et al. KAP1, a novel substrate for PIKK family members, colocalizes with numerous damage response factors at DNA lesions. Cancer Res 2006; 66:11594–11599.
Ziv Y, Bielopolski D, Galanty Y, et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat Cell Biol 2006; 8:870–876.
Lim DS, Kim ST, Xu B, et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 2000; 404:613–617.
Kitagawa R, Bakkenist CJ, McKinnon PJ, et al. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev 2004; 18:1423–1438.
Bernier J, Bentzen SM, Vermorken JB . Molecular therapy in head and neck oncology. Nat Rev Clin Oncol 2009; 6:266–277.
Park SY, Kim YM, Pyo H . Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated. Mol Cancer 2010; 9:222.
Lin HQ, Meriaty H, Katsifis A . Prediction of synergistic antitumour effect of gefitinib and radiation in vitro. Anticancer Res 2011; 31:2883–2888.
Kang KB, Zhu C, Wong YL, et al. Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair. Int J Radiat Oncol Biol Phys 2012; 83:e43–e52.
Lee MJ, Ye AS, Gardino AK, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012; 149:780–794.
Das AK, Chen BP, Story MD, et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res 2007; 67:5267–5274.
Kaidi A, Jackson SP . KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature 2013; 498:70–74.
Wang Q, Villeneuve G, Wang Z . Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. EMBO Rep 2005; 6:942–948.
Bjorkelund H, Gedda L, Barta P, et al. Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with (1)(2)(5)I-EGF. PLoS One 2011; 6:e24739.
Chen BP, Uematsu N, Kobayashi J, et al. Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem 2007; 282:6582–6587.
Liu M, Lee DF, Chen CT, et al. IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression. Mol Cell 2012; 45:171–184.
Acknowledgements
We thank Drs Michael B Kastan and Cheryl L Walker for providing Flag-tagged ATM plasmid and Dr Jennifer L Hsu for editing the manuscript. This study was funded in part by the following: National Institutes of Health (CA109311, CA099031, and CCSG CA16672); The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund (to M-C H); Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03); Program for Stem Cell and Regenerative Medicine Frontier Research (NSC102-2321-B-039-001); International Research-Intensive Centers of Excellence (NSC103-2911-I-002-303); Center for Biological Pathways; Competitive Medical Research Fund (CMRF) of the University of Pittsburgh Medical Center (to LL); and National Institutes of Health (AG045545-01 to LL). This work is in memoriam of Mr Tiong Loi Ang for his courageous fight against cancer.
Author information
Authors and Affiliations
Corresponding author
Additional information
( Supplementary information is linked to the online version of the paper on the Cell Research website.)
Supplementary information
Supplementary information, Figure S1
ATM is tyrosine phosphorylated at residue 370. (PDF 367 kb)
Supplementary information, Figure S2
Schematic of DR-GFP reporter integrated in U2OS cell and schematic of the KillerRed system in U2OS TRE cells. (PDF 87 kb)
Supplementary information, Figure S3
EGFR co-localizes with γ-H2AX at laser microirradiation-induced DSBs and is required for ATM S1981 autophosphorylation upon IR stimulation. (PDF 340 kb)
Supplementary information, Figure S4
ATM Y370 is a major EGFR-mediated phosphorylation site. (PDF 1043 kb)
Supplementary information, Figure S5
ATM Y370 phosphorylation regulates radiosensitivity. (PDF 255 kb)
Supplementary information, Figure S6
Proposed model showing the role of EGFR in ATM-mediated DNA damage response. (PDF 49 kb)
Supplementary information, Data S1
Materials and Methods (PDF 123 kb)
Rights and permissions
About this article
Cite this article
Lee, HJ., Lan, L., Peng, G. et al. Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response. Cell Res 25, 225–236 (2015). https://doi.org/10.1038/cr.2015.8
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/cr.2015.8
Keywords
This article is cited by
-
Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities
Nature Communications (2023)
-
Targeting DNA-PK overcomes acquired resistance to third-generation EGFR-TKI osimertinib in non-small-cell lung cancer
Acta Pharmacologica Sinica (2021)
-
Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages
Nature Communications (2019)
-
A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases
Journal of Biomedical Science (2018)
-
ROS-induced R loops trigger a transcription-coupled but BRCA1/2-independent homologous recombination pathway through CSB
Nature Communications (2018)